Clinical Trials Directory

Trials / Completed

CompletedNCT00805155

Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions

Bioequivalence of Three Mometasone Furoate 0.1% Topical Lotions

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Padagis LLC · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Mometasone Furoate 0.1% Topical Lotions in healthy, female subjects.

Conditions

Interventions

TypeNameDescription
DRUGMometasone Furoate 0.1% Topical Lotion-Reference ProductSmall amount applied and evaluated over the course of two days. ChromaMeter used to measure response.
DRUGMometasone Furoate 0.1% Topical Lotion-Test product 1Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response.
DRUGMometasone Furoate 0.1% Topical Lotion-Test Product 2Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response.

Timeline

Start date
2004-02-01
Primary completion
2004-03-01
Completion
2004-03-01
First posted
2008-12-09
Last updated
2021-10-15

Source: ClinicalTrials.gov record NCT00805155. Inclusion in this directory is not an endorsement.

Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions (NCT00805155) · Clinical Trials Directory